PRENTISS SMITH & CO INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRENTISS SMITH & CO INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,299,980
+0.1%
52,032
-0.9%
3.91%
-1.7%
Q2 2023$5,296,968
+9.4%
52,492
-0.3%
3.97%
+10.5%
Q1 2023$4,843,708
+0.2%
52,649
-1.2%
3.60%
-17.9%
Q4 2022$4,833,380
+17.9%
53,278
-1.2%
4.38%
+20.1%
Q3 2022$4,101,000
-10.4%
53,951
-0.4%
3.65%
+3.3%
Q2 2022$4,577,000
-5.2%
54,147
-1.6%
3.53%
+21.9%
Q1 2022$4,829,000
-2.6%
55,026
-2.9%
2.90%
+23.7%
Q4 2021$4,959,000
+6.9%
56,691
-0.1%
2.34%
-0.6%
Q3 2021$4,639,000
-10.6%
56,720
-0.3%
2.36%
-5.8%
Q2 2021$5,190,000
+4.7%
56,885
-1.9%
2.50%
-1.9%
Q1 2021$4,957,000
-19.1%
57,986
-10.7%
2.55%
-12.9%
Q4 2020$6,129,000
+6.7%
64,905
-1.7%
2.92%
-2.3%
Q3 2020$5,742,000
-3.4%
66,026
-3.0%
2.99%
-18.4%
Q2 2020$5,944,000
+6.0%
68,059
+0.0%
3.67%
-5.8%
Q1 2020$5,609,000
-13.6%
68,027
-0.8%
3.89%
-6.6%
Q4 2019$6,492,000
+7.3%
68,561
-1.5%
4.17%
+2.8%
Q3 2019$6,048,000
-5.2%
69,603
-0.4%
4.05%
-2.6%
Q2 2019$6,380,000
-28.0%
69,867
-24.2%
4.16%
-26.1%
Q1 2019$8,864,000
-14.9%
92,194
-24.1%
5.63%
-14.1%
Q4 2018$10,419,000
-0.8%
121,419
-0.4%
6.56%
+9.6%
Q3 2018$10,503,000
+12.8%
121,901
-1.1%
5.99%
+6.2%
Q2 2018$9,312,000
-9.3%
123,274
-2.9%
5.64%
+4.8%
Q1 2018$10,268,000
-3.3%
127,005
+0.4%
5.38%
+3.9%
Q4 2017$10,622,000
-51.0%
126,518
-49.9%
5.18%
-18.9%
Q3 2017$21,675,000
+101.5%
252,480
+95.9%
6.39%
+13.5%
Q2 2017$10,759,000
+6.2%
128,894
-5.5%
5.63%
-2.0%
Q1 2017$10,133,000
+4.4%
136,441
+2.4%
5.74%
-2.9%
Q4 2016$9,702,000
-9.0%
133,202
-1.4%
5.92%
-0.8%
Q3 2016$10,665,000
-4.7%
135,071
-0.4%
5.96%
-5.4%
Q2 2016$11,194,000
+15.5%
135,673
+1.5%
6.30%
+13.0%
Q1 2016$9,688,000
-13.1%
133,732
+3.2%
5.58%
-5.4%
Q4 2015$11,152,000
-4.9%
129,618
+1.7%
5.90%
-9.2%
Q3 2015$11,721,000
-2.7%
127,510
+4.1%
6.50%
+9.9%
Q2 2015$12,041,000
-6.5%
122,446
-6.2%
5.92%
-3.9%
Q1 2015$12,878,000
+1.5%
130,593
-4.7%
6.15%
+4.4%
Q4 2014$12,692,000
-2.7%
136,972
-1.2%
5.90%
-9.4%
Q3 2014$13,050,000
+1.6%
138,634
-2.3%
6.51%
-0.3%
Q2 2014$12,846,000
+5.1%
141,895
-1.3%
6.53%
+0.7%
Q1 2014$12,227,000
+3.9%
143,809
-1.8%
6.48%
+5.3%
Q4 2013$11,768,000
-1.9%
146,405
-6.4%
6.16%
-1.1%
Q3 2013$11,999,000
+112.5%
156,421
+95.9%
6.22%
+112.9%
Q2 2013$5,647,00079,8572.92%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders